SK Biopharmaceuticals Co., Ltd. (326030.KS) KSC

127,000.00

-1500(-1.17%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap8.7T
Enterprise Value8.56T
P/E Ratio31.02
PEG Ratio1.23
Price/Sales Ratio14.73
Price/Book Ratio14.78
Enterprise/Revenue14.42
Enterprise/EBITDA34.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.47
Operating Margin0.29

Management Effectiveness

Return On Assets0.31
Return On Equity0.54

Income Statement

Revenue547.6B
Revenue/Share8,627.41
Gross Profit504.5B
EBITDA100.71B
Net Income240.74B
Diluted EPS3,066.97

Balance Sheet

Total Cash256.16B
Total Cash/Share3,272.17
Total Debt49.37B
Total Debt/Equity0.07
Current Ratio2.43
Book Value Per Share8,806.88

Price History

52-Week Change21.53
52-Week High144,100
52-Week Low86,900
Moving Average 50 Days124,638
Moving Average 200 Days105,942.5

Statistics

Average Volume268,764
Shares Outstanding78.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A